Ethos Technologies (LIFE) Director John H. Kunze Receives 7,592 RSUs
$LIFE · Ethos Technologies Inc.Research Summary
AI-generated summary of this SEC filing
Ethos Technologies (LIFE) Director John H. Kunze Receives 7,592 RSUs
What Happened John H. Kunze, a director of Ethos Technologies, received an award of 7,592 restricted stock units (RSUs) on 2026-08-08. The RSUs were granted at $0.00 (no cash cost to Kunze) and therefore have an initial transaction value of $0 on the Form 4. This is an equity compensation award (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-08-08; Form 4 filed: 2026-08-11 (filed within two business days).
- Grant type/code: A (award/grant) — 7,592 RSUs @ $0.00.
- Shares owned after transaction: Not specified in the filing.
- Footnote F1: RSUs vest 25% on each of Nov 8, 2026; Feb 8, 2027; May 8, 2027; and Aug 8, 2027, provided continuous service. The unvested portion will fully vest on the earlier of (i) the first anniversary of grant and (ii) the Issuer’s 2027 annual meeting, subject to continuous service.
- Footnote F2: The reported total includes shares issuable upon settlement of the RSUs.
- No 10b5-1 plan, tax-withholding or sale-on-vesting details were disclosed in this Form 4.
Context RSUs are a common form of executive/director compensation — they represent a promise to issue shares upon vesting and are not an immediate market purchase or sale. Because this grant carries a $0 acquisition price and vests over time, it does not by itself signal an immediate buy or sell action by the insider; any future sales would depend on vesting, company policy, and the insider’s subsequent decisions.